I’m excited to share a deeper look into my professional journey and the experiences that have shaped my career in healthcare and commercial leadership. Over the years, I’ve had the opportunity to lead incredible teams, drive meaningful growth, and contribute to organizations focused on improving patient outcomes. I’m passionate about making a positive impact and continuing to grow through new opportunities, including board service. Here is my biography.

I am excited to share a deeper look into my professional journey across global pharmaceutical and biotechnology leadership. Over the past several decades, I have been fortunate to support groundbreaking therapies in oncology, rare diseases, diagnostics, and radiopharmaceuticals, always guided by my commitment to putting patients first. Here is my biography.

I am excited to share my professional biography, which reflects my journey through more than twenty-five years in healthcare and pharmaceuticals. From leading market access and trade strategies at Sanofi, CVS Health, and McKesson to shaping innovative distribution and specialty pharmacy solutions, I’ve been fortunate to work across every part of the healthcare ecosystem. My passion lies in advancing patient access, building strong partnerships, and mentoring the next generation of leaders.

I'm excited to share a deeper look into my professional journey—spanning over 30 years of experience in healthcare, technology, and data strategy. Throughout my career, I've focused on building strong teams, driving innovation, and creating meaningful value for patients, providers, and partners. Here is my biography.

Arup Pramanik is a globally recognized healthcare executive who has spent 25 years transforming how innovation reaches patients. With deep expertise in market access, pricing strategy, and digital health, Arup has led major global initiatives across top pharmaceutical companies including Boehringer Ingelheim, Novartis, and Takeda. Known for uniting science with strategy, he has reshaped commercialization pathways through AI, real-world evidence, and value-based models—delivering outcomes that benefit both enterprise growth and health equity. Now preparing for board roles, Arup brings unmatched global insight, cross-sector leadership, and a bold vision for patient-centered innovation.

I'm a global medical affairs leader with over two decades of experience spanning clinical research, regulatory strategy, and pharmaceutical innovation across Latin America and the United States. Throughout my career, I've had the privilege of guiding high-performing teams, launching impactful therapies, and aligning regional execution with global vision—most recently as Head of Medical Affairs for Emerging Therapy Areas at Novo Nordisk. Passionate about advancing patient outcomes and fostering collaborative leadership, I bring a strategic, people-centered approach to everything I do in the healthcare space.

After nearly three decades of experience across the pharmaceutical and life sciences industries, I’m proud to share my executive biography. From commercial launches to global partnerships, keynote speaking, and team leadership, I’ve been fortunate to work with some incredible people and companies, all driven by a common mission: improving lives through innovative medicine.

Mary Cantu is a seasoned healthcare executive with over two decades of experience leading global market access, reimbursement strategy, and health policy across the medical device and pharmaceutical industries. Renowned for her ability to navigate complex regulatory and payer landscapes, she has successfully developed and executed comprehensive access strategies that drive product adoption, secure favorable coverage and coding, and expand patient access across domestic and international markets. With a proven track record of aligning cross-functional teams around clear, value-based goals, Mary brings strategic vision, operational excellence, and a deep commitment to healthcare innovation to every stage of the product lifecycle.

Sejal Jonas, PharmD, RPh, is a visionary healthcare executive with over three decades of experience shaping payer strategy, formulary management, and market access for some of the nation’s leading pharmaceutical and healthcare organizations. Known for her deep clinical knowledge, strategic acumen, and commitment to improving health outcomes, Sejal brings a rare ability to bridge the gap between innovation and execution. Her work has empowered brands to thrive in complex regulatory and reimbursement environments, while her leadership continues to influence how healthcare systems deliver value to patients and providers alike.

Matthew C. Hedberg is a seasoned State Government Affairs and Health Policy Executive with 27 years of experience shaping legislative and regulatory landscapes across consumer brands, healthcare, pharmaceuticals, manufacturing, and technology. A trusted strategist and corporate advocate, he has successfully led high-stakes negotiations, influenced critical policy decisions, and built lasting relationships with policymakers, executives, and industry leaders. His expertise spans state and federal healthcare policies, market access, economic development, and corporate governance, making him a vital asset for organizations navigating complex regulatory environments. Known for his integrity, strategic foresight, and ability to drive consensus, Matthew leverages his deep knowledge and communication skills to align business objectives with policy initiatives, ensuring sustainable growth and industry leadership.

After an incredible career in pharmaceutical sales, biotechnology, and market access, I’m excited to share my executive biography. With over 35 years of experience leading high-performing teams, driving business growth, and shaping strategic sales initiatives, I remain passionate about mentoring, leadership development, and business strategy. I look forward to new opportunities to contribute my expertise and continue making an impact. Here is my biography.

Michael Ekstut is a seasoned business leader with over 30 years of experience in the life sciences industry, specializing in drug discovery, development, and regulatory strategy. He has held senior leadership roles at industry-leading companies, including Certara, where he guided the company’s commercial and product strategy in the regulatory and access sector. Michael is known for his strategic vision and ability to drive innovation, optimizing clinical development programs and supporting biopharma companies in navigating complex regulatory landscapes. His deep expertise in business consulting, technology, and operational management has enabled him to successfully advise executives and investors across pharmaceuticals, biotechnology, and medical devices. Currently serving as a Senior Advisor at InSilicoTrials, Michael continues to leverage his vast experience to help organizations maximize the impact of their clinical development programs and investments.

I’m thrilled to share my updated executive biography, detailing my journey and experiences in the BioPharma sector. With over 26 years of experience in Marketing, Sales, and Operations, I’ve had the privilege of leading innovative projects and driving significant growth at companies like Evofem Biosciences. In my role, I focus on crafting and executing strategic initiatives that enhance patient care and advance healthcare solutions. My commitment to integrity, strategic excellence, and effective communication has guided me in achieving impactful results and fostering empowered teams.